↓ Skip to main content

Are sulfonylureas passé?

Overview of attention for article published in Current Diabetes Reports, September 2006
Altmetric Badge

Mentioned by

video
2 video uploaders

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
14 Mendeley
Title
Are sulfonylureas passé?
Published in
Current Diabetes Reports, September 2006
DOI 10.1007/s11892-006-0008-9
Pubmed ID
Authors

Jennifer B. Green, Mark N. Feinglos

Abstract

Sulfonylureas and similarly acting rapid insulin secretagogues have long been available to manage type 2 diabetes. These agents have a well understood mechanism of action and are in large part well tolerated. However, sulfonylurea therapy is unlikely to sustain adequate long-term glycemic control and has potential side effects, including hypoglycemia and weight gain. Additional concerns exist regarding detrimental effects of certain sulfonylureas on ischemic preconditioning and cardiac outcomes. Fortunately, newer agents such as glimepiride appear less likely to adversely affect the myocardium. These agents can often be used successfully as one component of combination therapy for diabetes management.

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 7%
Unknown 13 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 29%
Student > Ph. D. Student 3 21%
Researcher 3 21%
Professor > Associate Professor 2 14%
Student > Doctoral Student 1 7%
Other 1 7%
Readers by discipline Count As %
Medicine and Dentistry 6 43%
Agricultural and Biological Sciences 5 36%
Unspecified 2 14%
Design 1 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 June 2019.
All research outputs
#10,788,452
of 13,555,081 outputs
Outputs from Current Diabetes Reports
#535
of 761 outputs
Outputs of similar age
#184,805
of 266,322 outputs
Outputs of similar age from Current Diabetes Reports
#11
of 19 outputs
Altmetric has tracked 13,555,081 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 761 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 266,322 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.